Ridker PM - Search Results

1

Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium.

Blankenberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, Jørgensen T, Thorand B, Peters A, Nauck M, Petersmann A, Vartiainen E, Veronesi G, Brambilla P, Costanzo S, Iacoviello L, Linden G, Yarnell J, Patterson CC, Everett BM, Ridker PM, Kontto J, Schnabel RB, Koenig W, Kee F, Zeller T, Kuulasmaa K; BiomarCaRE Investigators. Blankenberg S, et al. Among authors: ridker pm. Eur Heart J. 2016 Aug 7;37(30):2428-37. doi: 10.1093/eurheartj/ehw172. Epub 2016 May 12. Eur Heart J. 2016. PMID: 27174290 Free PMC article.

2

Current and future perspectives on antithrombotic therapy of acute myocardial infarction.

Hennekens CH, O'Donnell CJ, Ridker PM. Hennekens CH, et al. Among authors: ridker pm. Eur Heart J. 1995 Jul;16 Suppl D:2-9. doi: 10.1093/eurheartj/16.suppl_d.2. Eur Heart J. 1995. PMID: 8542867 Review.

3

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Ridker PM, Hennekens CH, Buring JE, Rifai N. Ridker PM, et al. N Engl J Med. 2000 Mar 23;342(12):836-43. doi: 10.1056/NEJM200003233421202. N Engl J Med. 2000. PMID: 10733371 Free article.

4

Soluble P-selectin and the risk of future cardiovascular events.

Ridker PM, Buring JE, Rifai N. Ridker PM, et al. Circulation. 2001 Jan 30;103(4):491-5. doi: 10.1161/01.cir.103.4.491. Circulation. 2001. PMID: 11157711

5

High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.

Ridker PM. Ridker PM. Circulation. 2001 Apr 3;103(13):1813-8. doi: 10.1161/01.cir.103.13.1813. Circulation. 2001. PMID: 11282915

6

Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis.

Blake GJ, Schmitz C, Lindpaintner K, Ridker PM. Blake GJ, et al. Among authors: ridker pm. Eur Heart J. 2001 Dec;22(24):2262-6. doi: 10.1053/euhj.2001.2692. Eur Heart J. 2001. PMID: 11728146

7

Inflammatory bio-markers and cardiovascular risk prediction.

Blake GJ, Ridker PM. Blake GJ, et al. Among authors: ridker pm. J Intern Med. 2002 Oct;252(4):283-94. doi: 10.1046/j.1365-2796.2002.01019.x. J Intern Med. 2002. PMID: 12366601 Free article. Review.

8

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Ridker PM, et al. N Engl J Med. 2002 Nov 14;347(20):1557-65. doi: 10.1056/NEJMoa021993. N Engl J Med. 2002. PMID: 12432042 Free article.

9

Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial.

Blake GJ, Albert MA, Rifai N, Ridker PM. Blake GJ, et al. Among authors: ridker pm. Eur Heart J. 2003 Oct;24(20):1843-7. doi: 10.1016/j.ehj.2003.07.008. Eur Heart J. 2003. PMID: 14563343 Clinical Trial.

10

Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS).

Mason PJ, Manson JE, Sesso HD, Albert CM, Chown MJ, Cook NR, Greenland P, Ridker PM, Glynn RJ. Mason PJ, et al. Among authors: ridker pm. Circulation. 2004 Apr 6;109(13):1623-9. doi: 10.1161/01.CIR.0000124488.06377.77. Epub 2004 Mar 15. Circulation. 2004. PMID: 15023883 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,161 results

Search Page

Filters